Anna S. Berghoff

14.7k total citations · 2 hit papers
292 papers, 7.4k citations indexed

About

Anna S. Berghoff is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Anna S. Berghoff has authored 292 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Oncology, 149 papers in Pulmonary and Respiratory Medicine and 87 papers in Genetics. Recurrent topics in Anna S. Berghoff's work include Brain Metastases and Treatment (124 papers), Glioma Diagnosis and Treatment (84 papers) and Lung Cancer Research Studies (62 papers). Anna S. Berghoff is often cited by papers focused on Brain Metastases and Treatment (124 papers), Glioma Diagnosis and Treatment (84 papers) and Lung Cancer Research Studies (62 papers). Anna S. Berghoff collaborates with scholars based in Austria, Germany and United States. Anna S. Berghoff's co-authors include Matthias Preusser, Georg Widhalm, Peter Birner, Rupert Bartsch, Karin Dieckmann, Christoph Zielinski, Johannes A. Hainfellner, Orsolya Rajky, Adelheid Wöhrer and Angelika M. Starzer and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Anna S. Berghoff

272 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

2014 445 citations Anna S. Berghoff, Barbara Kiesel et al. Neuro-Oncology profile →
Quantitative evidence for early metastatic seeding in colorectal cancer

2019 289 citations Anna S. Berghoff, Matthias Preusser et al. profile →

Peers

Countries citing papers authored by Anna S. Berghoff

Since Specialization

Citations

This map shows the geographic impact of Anna S. Berghoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna S. Berghoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna S. Berghoff more than expected).

Fields of papers citing papers by Anna S. Berghoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna S. Berghoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna S. Berghoff. The network helps show where Anna S. Berghoff may publish in the future.

Co-authorship network of co-authors of Anna S. Berghoff

This figure shows the co-authorship network connecting the top 25 collaborators of Anna S. Berghoff. A scholar is included among the top collaborators of Anna S. Berghoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna S. Berghoff. Anna S. Berghoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	450MO Characterization of tumor-infiltrating lymphocytes and tumor-associated macrophages within the tumor microenvironment of primary tumors and matched brain metastases 2024 ·Annals of Oncology ·(unknown), (unknown), (unknown), Erwin Tomasich, Maximilian J. Mair, Ariane Steindl, Zunamys I. Carrero, (unknown), Johannes A. Hainfellner, Leonhard Müllauer, Gerwin Heller, Matthias Preusser, Jakob Nikolas Kather, Anna S. Berghoff	0
2	23P Non-small cell lung cancer DNA methylation profiles correlate with immune checkpoint inhibitor response 2024 ·Immuno-Oncology Technology ·J.M. Berger, Erwin Tomasich, (unknown), (unknown), (unknown), (unknown), (unknown), M. Korpan, Ulrike Setinek, (unknown), (unknown), Lucian Beer, Helmut Prosch, Renate Kain, Julia Furtner, Gerwin Heller, Matthias Preusser, Anna S. Berghoff	1
3	Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial 2023 ·Infectious Agents and Cancer ·Maximilian J. Mair, (unknown), (unknown), Rainer Puhr, (unknown), Marlene Troch, Hannah Christina Puhr, Angelika M. Starzer, Ariane Steindl, (unknown), Helmuth Haslacher, Thomas Perkmann, Christoph Minichsdorfer, Gerald W. Prager, Wolfgang Lamm, Anna S. Berghoff, Barbara Kiesewetter, Markus Zeitlinger, Matthias Preusser, Markus Raderer	1
4	Malignant ascites: Current therapy options and treatment prospects 2023 ·Cancer Treatment Reviews ·J.M. Berger, Matthias Preusser, Anna S. Berghoff, Elisabeth Bergen	14
5	Clinical risk factors for ascites in metastatic pancreatic cancer 2023 ·ESMO Open ·J.M. Berger, (unknown), Rainer Puhr, (unknown), (unknown), Bernhard Scheiner, Gerald W. Prager, Anna S. Berghoff, Matthias Preusser, Elisabeth Bergen	5
6	537P S100A9 serum levels are associated with survival prognosis in patients with brain metastases 2023 ·Annals of Oncology ·Ariane Steindl, Arne Kienzle, Erwin Tomasich, J.M. Berger, (unknown), (unknown), M. Korpan, (unknown), Angelika M. Starzer, Barbara Kiesel, Georg Widhalm, Franziska Eckert, Matthias Preusser, Anna S. Berghoff	1
7	Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours 2023 ·Nature Reviews Clinical Oncology ·Maximilian J. Mair, Rupert Bartsch, Émilie Le Rhun, Anna S. Berghoff, Priscilla K. Brastianos, Javier Cortés, Hui Gan, Nancy U. Lin, Andrew B. Lassman, Patrick Y. Wen, Michael Weller, Martin J. van den Bent, Matthias Preusser	45
8	Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer 2023 ·Clinical Cancer Research ·Erwin Tomasich, Ariane Steindl, (unknown), (unknown), (unknown), (unknown), Rainer Puhr, Johannes A. Hainfellner, Leonhard Müllauer, Georg Widhalm, Franziska Eckert, Rupert Bartsch, Gerwin Heller, Matthias Preusser, Anna S. Berghoff	14
9	Career and Professional Development for Young Oncologists 2022 ·Oncology Research and Treatment ·Maximilian J. Mair, (unknown), Elizabeth A. Connolly, Maria Kfoury, Matteo Lambertini, Kok Haw Jonathan Lim, (unknown), Alexios Matikas, Rille Pihlak, Kevin Punie, Christoph Oing, Rodrigo Sánchez-Bayona, Paweł Sobczuk, Hongcheng Zhu, Anna S. Berghoff, Teresa Amaral	2
10	Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns 2022 ·Clinical Cancer Research ·Maximilian J. Mair, (unknown), Gerwin Heller, Rainer Puhr, Erwin Tomasich, (unknown), (unknown), Adelheid Wöhrer, Georg Widhalm, Karin Dieckmann, Martin Aichholzer, Serge Weis, Tim J. von Oertzen, Julia Furtner, Josef Pichler, Matthias Preusser, Anna S. Berghoff	8
11	Gender equality in oncology The importance of representation 2021 ·Pilar Garrido, Anna S. Berghoff, Cristiana Sessa, (unknown), (unknown), (unknown)	0
12	5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers 2021 ·Cancers ·Arthur Hosmann, Matthias Millesi, Lisa I. Wadiura, Barbara Kiesel, (unknown), Mario Mischkulnig, Martin Borkovec, Julia Furtner, Thomas Roetzer-Pejrimovsky, Stefan Wolfsberger, Joanna J. Phillips, Anna S. Berghoff, Shawn L. Hervey‐Jumper, Mitchel S. Berger, Georg Widhalm	28
13	Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years 2021 ·Cancers ·Barbara Kiesel, Lisa I. Wadiura, Mario Mischkulnig, (unknown), (unknown), Martin Borkovec, Julia Freund, (unknown), Matthias Millesi, Anna S. Berghoff, Julia Furtner, Adelheid Wöehrer, Georg Widhalm	7
14	Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540” 2021 ·Cancers ·Arthur Hosmann, Matthias Millesi, Lisa I. Wadiura, Barbara Kiesel, (unknown), Mario Mischkulnig, Martin Borkovec, Julia Furtner, Thomas Roetzer-Pejrimovsky, Stefan Wolfsberger, Joanna J. Phillips, Anna S. Berghoff, Shawn L. Hervey‐Jumper, Mitchel S. Berger, Georg Widhalm	4
15	Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer 2020 ·European Journal of Cancer ·Anna S. Berghoff, (unknown), Angelika M. Starzer, Nicolás Ballarini, Fabian Wolpert, Elisabeth Bergen, Peter Wolf, Ariane Steindl, Georg Widhalm, Brigitte Gatterbauer, Christine Marosi, Karin Dieckmann, Rupert Bartsch, Thomas Scherer, Franz Koenig, Michael Krebs, Michael Weller, Matthias Preusser	12
16	Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors 2020 ·Neuro-Oncology ·Émilie Le Rhun, Patrick Devos, Johannes Weller, Katharina Seystahl, Francesca Mo, Annette Compter, Anna S. Berghoff, Joost L.M. Jongen, Fabian Wolpert, Roberta Rudà, Dieta Brandsma, Martin J. van den Bent, Matthias Preusser, Ulrich Herrlinger, Michael Weller	69
17	Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases 2019 ·Clinical Cancer Research ·Elisabeth Bergen, Anna S. Berghoff, (unknown), Margaretha Rudas, Florian Fitzal, Zsuzsanna Bagó-Horváth, Karin Dieckmann, Robert M. Mader, Ruth Exner, Michael Gnant, Christoph Zielinski, Guenther G. Steger, Matthias Preusser, Rupert Bartsch	33
18	Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin 2018 ·Cancer Discovery ·Dian Yang, Sarah K. Denny, Peyton Greenside, Andrea C. Chaikovsky, Jennifer J. Brady, Youcef Ouadah, Jeffrey M. Granja, Nadine S. Jahchan, Jing Lim, Shirley Kwok, Christina S. Kong, Anna S. Berghoff, Anna Schmitt, Hans Christian Reinhardt, (unknown), Matthias Preusser, Anshul Kundaje, William J. Greenleaf, Julien Sage, Monte M. Winslow	104
19	Impact of Blood–Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases 2016 ·Clinical Cancer Research ·Matthias Osswald, Jonas Blaes, Yunxiang Liao, Gergely Solecki, Miriam Gömmel, Anna S. Berghoff, Laurent Salphati, Jeffrey J. Wallin, Heidi Phillips, Wolfgang Wick, Frank Winkler	88
20	Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment 2016 ·American Society of Clinical Oncology Educational Book ·Anna S. Berghoff, Vyshak Alva Venur, Matthias Preusser, Manmeet S. Ahluwalia	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact